专题：Monoclonal and Polyclonal Antibodies Research

This cluster of papers focuses on the development, engineering, and applications of therapeutic antibodies, including their interaction with Fc receptors, monoclonal antibody therapy for cancer, antibody engineering techniques such as nanobodies and bispecific antibodies, the impact of glycosylation on antibody function, and antibody pharmacokinetics.
最新文献
Exploring the next generation of antibody–drug conjugates

review Full Text OpenAlex

Cancer neoepitopes viewed through negative selection and peripheral tolerance: a new path to cancer vaccines

article Full Text OpenAlex

High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies

article Full Text OpenAlex

FLAb: Benchmarking deep learning methods for antibody fitness prediction

preprint Full Text OpenAlex

Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy

article Full Text OpenAlex

Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen

article Full Text OpenAlex

Profiling the interactome of oligonucleotide drugs by proximity biotinylation

article Full Text OpenAlex

A method for predicting linear and conformational B-cell epitopes in an antigen from its primary sequence

article Full Text OpenAlex

XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants

preprint Full Text OpenAlex

ImmuneMirror: A machine learning-based integrative pipeline and web server for neoantigen prediction

article Full Text OpenAlex

近5年高被引文献
Trends in peptide drug discovery

review Full Text OpenAlex 1678 FWCI119.57475581

Antibody drug conjugate: the “biological missile” for targeted cancer therapy

review Full Text OpenAlex 1268 FWCI189.78102162

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

article Full Text OpenAlex 969 FWCI144.94264838

Unlocking the potential of antibody–drug conjugates for cancer therapy

review Full Text OpenAlex 946 FWCI76.42215882

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

article Full Text OpenAlex 938 FWCI65.39046878

Teclistamab in Relapsed or Refractory Multiple Myeloma

article Full Text OpenAlex 917 FWCI205.46245584

Translational Applications of Hydrogels

review Full Text OpenAlex 909 FWCI60.61590688

Targeting HER2-positive breast cancer: advances and future directions

review Full Text OpenAlex 880 FWCI132.13168459

Management of Rheumatoid Arthritis: An Overview

review Full Text OpenAlex 860 FWCI125.25377681

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

article Full Text OpenAlex 841 FWCI105.65343533